Erythromycin Lactobionate for Injection pharmacological effects are: antibacterial activity against various anaerobes other than staphylococci, streptococci, gram-positive bacilli, fragile anaerobic bacilli and clostridia; sensitive to Neisseria, Haemophilus influenzae, Bowett’s disease of whooping cough and so on; inhibitory effect on Legionella, Campylobacter fetus, spirochetes, Mycoplasma pneumoniae, Rickettsiae, Chlamydiae.
Erythromycin Lactobionate for Injection is commonly used clinically as an alternative drug for patients with penicillin allergy.
Indications include acute tonsillitis or pharyngitis caused by hemolytic or Streptococcus pneumoniae, scarlet fever and cellulitis caused by hemolytic streptococci, diphtheria or diphtheria carriers, legionellosis, mycoplasma or chlamydia pneumonia, chlamydia or mycoplasma-induced genitourinary infections, Chlamydia trachomatis conjunctivitis, gonococcal infections, anaerobic oral infections, Campylobacter jejuni enterocolitis, and whooping cough.
Adverse reactions to Erythromycin Lactobionate for Injection include symptoms such as malaise, nausea and vomiting, abdominal pain, fever, jaundice, allergic reactions, cardiac arrhythmias, and oral or vaginal candida infections. High doses of the drug, especially in patients with liver or kidney disease or in elderly patients, may cause hearing loss, which usually returns to normal when the drug is discontinued.
In addition, it is contraindicated in patients who are allergic to erythromycins, pregnant women should use it with caution on balance, nursing women should suspend breastfeeding when using the drug, and the use of the drug in children and the elderly is not clear.
If you need to use Erythromycin Lactobionate for Injection, please consult a professional doctor and follow the doctor’s instructions to standardize the treatment, not blindly use the drug.